U.K. Drug Experts Wanted GSK's Avandia Withdrawn In July, But EU Processes Intervened
This article was originally published in The Pink Sheet Daily
Executive Summary
EU regulators will discuss the fate of GlaxoSmithKline's Avandia at an extraordinary meeting on Sept. 8, but a decision is not expected until the end of the month.